Description,Interaction type (Enzyme/Other),Bound complex,Unbound receptor,seqid (seqid_interface),Peptide sequence,Peptide sequence,Full peptide sequence + secondary structure,Bound-Unbound RMSd (interface)
Calpain small subunit 1,O,1NX1 AB:C (2.0A),1ALV AB (1.9A),100.0 (100.0),DAIDALSSDFT,DAIDALSSDFT,DAIDALSSDFT# HHHHHHHH,1.1A (1.0A)
AP-2 complex subunit alpha-2,O,2VJ0 A:P (1.6A),1B9K A (1.9A),100.0 (100.0),PKGWVTFE,NPKGWVTFEEEE,NPKGWVTFEEEE# TTS,1.3A (0.6A)
TNF receptor-associated factor 2,O,1CZY ABC:D (2.0A),1CA4 ABC (2.2A),99.4 (88.9),PQQATDD,XPQQATDD,XPQQATDD# EE S,0.6A (0.4A)
SH2 domain-containing protein 1A,O,1D4T A:B (1.1A),1D1Z A (1.4A),100.0 (90.0),KSLTIYAQVQK,KSLTIYAQVQK,KSLTIYAQVQK# SEEEE B,1.2A (5.2A)
Homer protein homolog 1,O,1DDV A:B (1.9A),1DDW A (1.7A),100.0 (100.0),TPPSPF,TPPSPF,TPPSPF# TT,0.6A (0.4A)
Dystrophin,O,1EG4 A:P (2.0A),1EG3 A (2.0A),100.0 (100.0),NMTPYRSPPPYVP,KNMTPYRSPPPYVPP,KNMTPYRSPPPYVPP# S,0.4A (1.8A)
Nuclear transport factor 2,O,1GYB AB:E (1.9A),1GY7 AB (1.6A),100.0 (100.0),GFSFG,DSGFSFGSK,DSGFSFGSK#,0.4A (0.2A)
Vitamin D3 receptor,O,2O4J A:C (1.7A),1IE9 A (1.4A),92.0 (100.0),KNHPMLMNLLKD,KNHPMLMNLLKDN,KNHPMLMNLLKDN# HHHHHHH,1.0A (0.5A)
Eukaryotic translation initiation factor 4E,O,2V8Y A:B (2.1A),1IPB A (2.0A),100.0 (87.5),RIIYDRKFLMECRN,RIIYDRKFLMECRN,RIIYDRKFLMECRN# HHHHHHT,0.9A (1.8A)
Chemotaxis protein CheY,O,2FMF A:B (2.0A),1JBE A (1.1A),98.4 (80.0),QDQVDDLLDSLGF,ASQDQVDDLLDSLGF,ASQDQVDDLLDSLGF# HHHHHHHHHHT,0.5A (0.8A)
NTF2-related export protein 1,O,1JN5 AB:C (2.8A),1JKG AB (1.9A),100.0 (100.0),PGFGQG,GQSPGFGQGGSV,GQSPGFGQGGSV# SS,0.3A (0.2A)
Genome polyprotein,O,1LVM AC:E (1.8A),1LVB AC (2.2A),97.7 (100.0),EATQLMN,EATQLMN,EATQLMN# EE,1.5A (0.9A)
Glutamate receptor-interacting protein 1,O,1N7F B:D (1.8A),1N7E A (1.5A),100.0 (100.0),ATVRTYSC,ATVRTYSC,ATVRTYSC# EEEE,0.4A (0.5A)
LAS seventeen-binding protein 3,O,1SSH A:B (1.4A),1OOT A (1.4A),100.0 (75.0),GPPPAMPARPT,EGPPPAMPARPT,EGPPPAMPARPT#,1.0A (2.8A)
Disabled homolog 2,O,1M7E A:D (2.5A),1P3R A (2.1A),100.0 (100.0),NGYENPTYK,NGYENPTYK,NGYENPTYK# EE TT,0.3A (0.4A)
Syntenin-1,O,1W9E A:T (1.6A),1R6J A (0.7A),100.0 (100.0),NEFYF,TNEFYF,TNEFYF# EE,2.7A (0.7A)
DNA polymerase sliding clamp,O,1RXZ A:B (2.0A),1RWZ A (1.8A),100.0 (86.7),KSTQATLERWF,KSTQATLERWF,KSTQATLERWF# EEE GGGT,0.7A (0.6A)
Disks large homolog 4,O,1TP5 A:B (1.5A),1TQ3 A (1.9A),100.0 (100.0),KKETWV,KKETWV,KKETWV# EE,0.8A (0.4A)
Microtubule-associated proteins 1A/1B light chain 3B,O,2ZJD A:B (1.6A),1UGM A (2.0A),98.2 (71.4),GGDDDWTHLS,SGGDDDWTHLS,SGGDDDWTHLS# TT EE,1.2A (3.8A)
Cationic trypsin,E,2AGE X:A (1.1A),1UTN A (1.1A),100.0 (100.0),AAPR,XAAPR,XAAPR# EE,0.3A (0.2A)
Kelch-like ECH-associated protein 1,O,1X2R A:B (1.7A),1X2J A (1.6A),100.0 (90.0),LDEETGEFL,LDEETGEFL,LDEETGEFL# TTT,0.7A (0.3A)
"1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1",O,1YWO A:P (1.8A),1YWP A (1.6A),100.0 (100.0),QPPVPPQRPM,QPPVPPQRPM,QPPVPPQRPM#,0.5A (0.4A)
Mineralocorticoid receptor,O,2A3I A:B (1.9A),2AAX A (1.8A),99.6 (60.0),QQKSLLQQLLTE,QQKSLLQQLLTE,QQKSLLQQLLTE# HHHHHHH,1.6A (4.9A)
Peptidyl-prolyl cis-trans isomerase A,E,1AWR C:I (1.6A),2ALF A (1.9A),98.8 (100.0),HAGPIA,HAGPIA,HAGPIA#,0.5A (0.4A)
Androgen receptor,O,1T7R A:B (1.4A),2AM9 A (1.6A),100.0 (100.0),SSRFESLFAG,SSRFESLFAGEKESR,SSRFESLFAGEKESR# HHHHHHHH,0.3A (0.7A)
Mitogen-activated protein kinase FUS3,E,2B9H A:C (1.6A),2B9F A (1.8A),99.4 (87.5),RRNLKGLNLNLH,RRNLKGLNLNLHPD,RRNLKGLNLNLHPD# TT,0.7A (0.5A)
ATP-dependent Clp protease ATP-binding subunit ClpX,O,2DS8 AB:Q (1.6A),2DS5 AB (1.5A),100.0 (66.7),ALRVVK,APALRVVK,APALRVVK# EE,0.9A (0.3A)
Ubiquitin carboxyl-terminal hydrolase 7,O,2FOJ A:B (1.6A),2F1W A (1.6A),100.0 (100.0),GARAHSS,GARAHSS,GARAHSS# B,2.7A (0.6A)
Rho guanine nucleotide exchange factor 7,O,2DF6 B:D (1.3A),2G6F X (0.9A),100.0 (100.0),PPVIAPRPEHTK,PPVIAPRPEHTKSIYTRS,PPVIAPRPEHTKSIYTRS# GGG,1.2A (0.7A)
WD repeat-containing protein 5,E,2H9M C:D (1.9A),2H14 A (1.5A),100.0 (100.0),ARTKQ,ARTKQTARKST,ARTKQTARKST# TT,0.6A (0.6A)
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,O,2HPL A:B (1.8A),2HPJ A (1.7A),100.0 (100.0),DDLYG,DDLYG,DDLYG# S,0.2A (0.3A)
Peroxisome proliferator-activated receptor gamma,O,1FM9 D:E (2.1A),2HWQ A (2.0A),100.0 (100.0),ERHKILHRLLQEGSPS,CPSSHSSLTERHKILHRLLQEGSPS,CPSSHSSLTERHKILHRLLQEGSPS# HHHHHHHHT,0.9A (0.5A)
Peroxisome proliferator-activated receptor gamma,O,2FVJ A:B (2.0A),2HWQ A (2.0A),100.0 (100.0),HKLVQLLTTT,QTSHKLVQLLTTT,QTSHKLVQLLTTT# HHHHHHH,0.7A (0.5A)
Proto-oncogene serine/threonine-protein kinase Pim-1,O,2C3I B:A (1.9A),2J2I B (1.9A),100.0 (100.0),KRRRHPSG,KRRRHPSG,KRRRHPSG#,0.4A (0.3A)
Sorbin and SH3 domain-containing protein 1,O,2O9V A:B (1.6A),2O9S A (0.8A),100.0 (100.0),VPPPVPPPPS,VPPPVPPPPS,VPPPVPPPPS#,0.7A (0.5A)
Serine/threonine-protein kinase Chk1,O,1NVR A:B (1.8A),2X8D A (1.9A),100.0 (100.0),ASVSA,ASVSA,ASVSA# EEE,0.3A (0.2A)
Peroxisome proliferator-activated receptor alpha,O,2P54 A:B (1.8A),2ZNN A (2.0A),100.0 (80.0),ARHKILHRLLQE,ARHKILHRLLQE,ARHKILHRLLQE# TTHHHHHHHH,0.8A (1.5A)